Aquilo Capital Management »

Sutro Biopharma shares owned by Aquilo Capital Management

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Aquilo Capital Management from 13F filings

Historical chart of Aquilo Capital Management investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Aquilo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Aquilo Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 421k 4.29

More positions owned by Aquilo Capital Management

Arrowhead Pharmaceuticals (ARWR)
Blueprint Medicines (BPMC)
Kymera Therapeutics (KYMR)
Arvinas Ord (ARVN)
Silence Therapeutics Ads (SLN)
S&p Biotech Etf Tr Unit Put Option (XBI)
Regenxbio Inc equity us cm (RGNX)
Merus N V (MRUS)
Repare Therapeutics Ord (RPTX)
Sutro Biopharma (STRO)

View all positions for Aquilo Capital Management

Top funds holding Sutro Biopharma

BVF
Vanguard Group
Franklin Resources
Kynam Capital Management
Baillie Gifford & Co
Samsara BioCapital
Millennium Management
Dimensional Fund Advisors
Goldman Sachs Group
Candriam Luxembourg S.C.A.
Vontobel Holding
PanAgora Asset Management
Pentwater Capital Management
Aquilo Capital Management
Jacobs Levy Equity Management

View all funds holding Sutro Biopharma